New targeted therapy eliminates cancer with zero side effects

Johannes Karges develops anti-cancer agents that work in a targeted manner, rather than adversely affecting the entire body.

Alnylam’s CEO on welcoming competition, turning a profit, and a ‘spine-tingling moment’

For the last 20 years Alnylam Pharmaceuticals has converted Nobel-winning research on RNA-based gene-silencing into medicines, winning approvals for drugs delivered to the liver. That’s

October 17, 2024

Opinion | From Doxxing to Doctor Death Threats

Vineet Arora, MD, MAPP, is an academic hospitalist and dean for medical education. Tricia Pendergrast, MD, is an anesthesiology resident. Regina Royan, MD, MPH, is

June 23, 2023

Mount Sinai researchers identify the structure of a special red blood cell transporter

Researchers at the Icahn School of Medicine at Mount Sinai have identified the structure of a special transporter found in red blood cells and how

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.